|
Online Database of Chemicals from Around the World | Search | Submit | Advertise |
Home >> Chemical Listing >> Darolutamide>> Market Analysis Reports |
Market Analysis Reports of Darolutamide |
|
Global Prostate Cancer Drugs Industry Research Report, Competitive Landscape, Market Size, Regional Status and Prospect ... Apalutamide Bicalutamide Cabazitaxel Casodex (Bicalutamide) Darolutamide Degarelix Docetaxel In Chapter 6 and Chapter ... Androgen Receptor Inhibitor Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type ... China's NMPA fast-tracks darolutamide, grappling with overtreatment in urban ... viability, emphasizing seizure-free profiles. Darolutamide: Emerging at a CAGR of 1.2%–2.0%, ARAMIS' ... volumes. Non-Metastatic Frontiers: Darolutamide's nmCRPC hold gains adjuvant ... Prostate Cancer Drugs Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Product Type ... androgen receptor inhibitors (e.g., enzalutamide, apalutamide, darolutamide), androgen synthesis inhibitors (e.g., abiraterone acetate ... USD 2.5–3.5 billion in 2024. Darolutamide: Marketed as Nubeqa by Bayer, darolutamide generated USD 1–2 billion in 2024 ... Prostate Cancer [2017] ... next-generation antiandrogens, apalutamide and darolutamide, be able to differentiate themselves in a competitive market ... ) Pipeline Therapies apalutamide (ARN-509; J&J) darolutamide (ODM-201; Bayer/Orion) PROSTVAC ... US Prostate Cancer Drug Market, Drug Price, Dosage & Clinical Trials Insight 2026 Please note: extra shipping charges are applied when purchasing Hard Copy License depending on the location. "US Prostate Cancer Drug Market, Drug Price, Dosage & Clinical Trials Insight 2026" Report Highlights: US Prostate Cancer Drug Market Opportunity ... Metastatic Prostate Cancer Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 The 7 major metastatic prostate cancer markets are expected to exhibit a CAGR of 6.22% during 2024-2034. The metastatic prostate cancer market has been comprehensively analyzed in IMARC's new report titled "Metastatic Prostate Cancer Market: Epidemiology, ... Triple-negative Breast Cancer Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 The triple-negative breast cancer market reached a value of US$ 490.5 Million across the top 7 markets (US, EU4, UK, and Japan) in 2023. Looking forward, IMARC Group expects the top 7 markets to reach US$ 773.2 Million by 2034, exhibiting a growth rate ( ... Global Prostate Cancer Treatment Market - 2025-2033 ... to evaluate the combination of opaganib and darolutamide in treating metastatic castrate-resistant prostate ... |